Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Summary

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer. Riluzole may help slow the growth of tumor cells. PURPOSE: This phase I trial is studying riluzole in women with stage I, stage II, or stage IIIA breast cancer.

Timeline

Start

2009-05

Primary completion

2011-06

Completion

2011-06

Drugs

Indications